Copyright
©2014 Baishideng Publishing Group Co.
World J Clin Oncol. May 10, 2014; 5(2): 164-169
Published online May 10, 2014. doi: 10.5306/wjco.v5.i2.164
Published online May 10, 2014. doi: 10.5306/wjco.v5.i2.164
Figure 1 Evolution of global costs of cancer drugs.
A: Evolution of global costs of cancer drugs used at the Department of Medical Oncology of Centro Hospitalar de Entre Douro e Vouga; B: Evolution of costs by type of drug administered at the Department of Medical Oncology of Centro Hospitalar de Entre Douro e Vouga; C: Evolution of costs of cancer drugs used at the Department of Medical Oncology of Centro Hospitalar de Entre Douro e Vouga, according to their market placement year.
Figure 2 Evolution of costs associated with therapy.
A: Evolution of costs associated with chemotherapy treatment at the Department of Medical Oncology of Centro Hospitalar de Entre Douro e Vouga according to the market placement year; B: Evolution of costs associated with targeted therapy at the Department of Medical Oncology of Centro Hospitalar de Entre Douro e Vouga according to the market placement year; C: Evolution of costs associated with endocrine therapy at the Department of Medical Oncology of Centro Hospitalar de Entre Douro e Vouga according to the market placement year.
- Citation: Peixoto V, Faria AL, Gonçalves M, Macedo J, Rego S, Macías E, Magano A, Loureiro M, Araújo A. Evolution of costs of cancer drugs in a Portuguese hospital. World J Clin Oncol 2014; 5(2): 164-169
- URL: https://www.wjgnet.com/2218-4333/full/v5/i2/164.htm
- DOI: https://dx.doi.org/10.5306/wjco.v5.i2.164